{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:47:53Z","timestamp":1768283273035,"version":"3.49.0"},"reference-count":44,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3892\/or.2015.4431","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T09:20:20Z","timestamp":1447752020000},"page":"825-832","source":"Crossref","is-referenced-by-count":19,"title":["Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats"],"prefix":"10.3892","volume":"35","author":[{"given":"MATTHEW T.","family":"COOK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BENFORD","family":"MAFUVADZE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CYNTHIA","family":"BESCH-WILLIFORD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARK R.","family":"ELLERSIECK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SANDY","family":"GOYETTE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SALMAN M.","family":"HYDER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,17]]},"reference":[{"key":"key20180107211138_b1-or-35-02-0825","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key20180107211138_b2-or-35-02-0825","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"key20180107211138_b3-or-35-02-0825","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"key20180107211138_b4-or-35-02-0825","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"key20180107211138_b5-or-35-02-0825","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","article-title":"Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial","volume":"49","author":"Fahl\u00e9n","year":"2013","journal-title":"Eur J Cancer"},{"key":"key20180107211138_b6-or-35-02-0825","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1048-891x.2004.014220.x","article-title":"Risk of progression in complex and atypical endometrial hyperplasia: Clinicopathologic analysis in cases with and without progestogen treatment","volume":"14","author":"Horn","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107211138_b7-or-35-02-0825","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/89.15.1110","article-title":"Estrogen-progestin replacement therapy and endometrial cancer","volume":"89","author":"Pike","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"key20180107211138_b8-or-35-02-0825","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrc3518","article-title":"Progesterone signalling in breast cancer: A neglected hormone coming into the limelight","volume":"13","author":"Brisken","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20180107211138_b9-or-35-02-0825","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis","volume":"468","author":"Gonzalez-Suarez","year":"2010","journal-title":"Nature"},{"key":"key20180107211138_b10-or-35-02-0825","first-page":"392","article-title":"Progestin regulation of vascular endothelial growth factor in human breast cancer cells","volume":"58","author":"Hyder","year":"1998","journal-title":"Cancer Res"},{"key":"key20180107211138_b11-or-35-02-0825","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1158\/0008-5472.CAN-07-1103","article-title":"Progestin-dependent progression of human breast tumor xenografts: A novel model for evaluating antitumor therapeutics","volume":"67","author":"Liang","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107211138_b12-or-35-02-0825","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/gme.0b013e3181d3dd0c","article-title":"Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice","volume":"17","author":"Liang","year":"2010","journal-title":"Menopause"},{"key":"key20180107211138_b13-or-35-02-0825","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsbmb.2004.12.011","article-title":"p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells","volume":"93","author":"Liang","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20180107211138_b14-or-35-02-0825","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/en.2005-0103","article-title":"Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: Paracrine and autocrine effects","volume":"146","author":"Liang","year":"2005","journal-title":"Endocrinology"},{"key":"key20180107211138_b15-or-35-02-0825","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature09091","article-title":"Progesterone induces adult mammary stem cell expansion","volume":"465","author":"Joshi","year":"2010","journal-title":"Nature"},{"key":"key20180107211138_b16-or-35-02-0825","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature09387","article-title":"Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer","volume":"468","author":"Schramek","year":"2010","journal-title":"Nature"},{"key":"key20180107211138_b17-or-35-02-0825","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-06-0427","article-title":"Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats","volume":"12","author":"Benakanakere","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107211138_b18-or-35-02-0825","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1940-6207.CAPR-10-0064","article-title":"Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats","volume":"3","author":"Benakanakere","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20180107211138_b19-or-35-02-0825","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/1940-6207.CAPR-10-0382","article-title":"Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a) anthracene-induced mammary tumors in Sprague-Dawley rats","volume":"4","author":"Mafuvadze","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20180107211138_b20-or-35-02-0825","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12672-012-0114-x","article-title":"Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors","volume":"3","author":"Mafuvadze","year":"2012","journal-title":"Horm Cancer"},{"key":"key20180107211138_b21-or-35-02-0825","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1080\/01635581.2013.833637","article-title":"Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model","volume":"65","author":"Mafuvadze","year":"2013","journal-title":"Nutr Cancer"},{"key":"key20180107211138_b22-or-35-02-0825","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156800908786241050","article-title":"Luteolin, a flavonoid with potential for cancer prevention and therapy","volume":"8","author":"Lin","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107211138_b23-or-35-02-0825","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/138955709787001712","article-title":"Distribution and biological activities of the flavonoid luteolin","volume":"9","author":"L\u00f3pez-L\u00e1zaro","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"key20180107211138_b24-or-35-02-0825","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3390\/molecules13102628","article-title":"Anti-carcinogenic effects of the flavonoid luteolin","volume":"13","author":"Seelinger","year":"2008","journal-title":"Molecules"},{"key":"key20180107211138_b25-or-35-02-0825","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.1158\/0008-5472.CAN-03-3104","article-title":"Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3\u2032-kinase activity","volume":"64","author":"Bagli","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107211138_b26-or-35-02-0825","doi-asserted-by":"crossref","first-page":"e52279","DOI":"10.1371\/journal.pone.0052279","article-title":"Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis","volume":"7","author":"Pratheeshkumar","year":"2012","journal-title":"PLoS One"},{"key":"key20180107211138_b27-or-35-02-0825","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1158\/0008-5472.CAN-05-4062","article-title":"Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: An implication for the antitumor potential of flavonoids","volume":"66","author":"Selvendiran","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107211138_b28-or-35-02-0825","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/01635580802100851","article-title":"Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids","volume":"60","author":"Luo","year":"2008","journal-title":"Nutr Cancer"},{"key":"key20180107211138_b29-or-35-02-0825","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12672-013-0150-1","article-title":"Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin","volume":"4","author":"Nordeen","year":"2013","journal-title":"Horm Cancer"},{"key":"key20180107211138_b30-or-35-02-0825","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/carcin\/bgl189","article-title":"Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells","volume":"28","author":"Fang","year":"2007","journal-title":"Carcinogenesis"},{"key":"key20180107211138_b31-or-35-02-0825","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/1535-7163.MCT-09-0191","article-title":"Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin","volume":"8","author":"Zhou","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key20180107211138_b32-or-35-02-0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2006.08.018","article-title":"Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a) anthracene-induced mammary tumors in rats","volume":"164","author":"Samy","year":"2006","journal-title":"Chem Biol Interact"},{"key":"key20180107211138_b33-or-35-02-0825","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/laban.254","article-title":"Estimation of rat mammary tumor volume using caliper and ultrasonography measurements","volume":"42","author":"Faustino-Rocha","year":"2013","journal-title":"Lab Anim (NY)"},{"key":"key20180107211138_b34-or-35-02-0825","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107211138_b35-or-35-02-0825","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr Rev"},{"key":"key20180107211138_b36-or-35-02-0825","doi-asserted-by":"crossref","first-page":"101","DOI":"10.59566\/IJBS.2011.7101","article-title":"Luteolin regulation of estrogen signaling and cell cycle pathway genes in MCF-7 human breast cancer cells","volume":"7","author":"Markaverich","year":"2011","journal-title":"Int J Biomed Sci"},{"key":"key20180107211138_b37-or-35-02-0825","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3835(98)00141-4","article-title":"Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids","volume":"130","author":"Le Bail","year":"1998","journal-title":"Cancer Lett"},{"key":"key20180107211138_b38-or-35-02-0825","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1006422302173","article-title":"Steroid hormone activity of flavonoids and related compounds","volume":"62","author":"Zand","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107211138_b39-or-35-02-0825","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/ijo.2012.1675","article-title":"The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development","volume":"42","author":"Carroll","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107211138_b40-or-35-02-0825","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2013.11.010","article-title":"Tracking progesterone receptor-mediated actions in breast cancer","volume":"142","author":"Knutson","year":"2014","journal-title":"Pharmacol Ther"},{"key":"key20180107211138_b41-or-35-02-0825","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ijc.1236","article-title":"Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells","volume":"92","author":"Hyder","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107211138_b42-or-35-02-0825","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/onc.2012.275","article-title":"Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4","volume":"32","author":"Cittelly","year":"2013","journal-title":"Oncogene"},{"key":"key20180107211138_b43-or-35-02-0825","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.0706216105","article-title":"Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts","volume":"105","author":"Horwitz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107211138_b44-or-35-02-0825","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0773.1997.tb00004.x","article-title":"Seasonal influence on 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats under controlled laboratory conditions","volume":"81","author":"L\u00f6scher","year":"1997","journal-title":"Pharmacol Toxicol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4431\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T12:18:09Z","timestamp":1748693889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,17]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,11,17]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.3892\/or.2015.4431"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4431","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,17]]}}}